Expression of TGFB2 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

TGFB2 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 15.17

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

21.4

Number of samples

141

Samples

Sample	Description	TPM
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	128.6
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	76.0
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	73.0
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	70.2
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	62.7
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	61.2
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	60.0
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	59.8
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	57.6
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	56.1
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	50.4
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	48.8
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	48.6
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	48.3
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	42.2
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	41.8
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	40.6
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	40.0
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	39.9
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	39.8
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	38.2
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	35.4
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	34.8
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	34.3
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	34.3
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	33.9
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	33.1
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	32.0
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	31.8
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	31.8
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	31.4
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	30.7
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	29.4
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	28.9
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	28.3
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	28.0
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	26.5
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	25.6
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	25.5
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	25.4
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	25.3
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	24.7
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	24.4
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	24.3
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	24.2
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	23.7
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	23.4
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	22.9
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	22.9
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	22.9
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	22.8
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	22.4
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	21.9
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	21.5
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	20.3
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	20.3
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	19.6
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	19.3
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	19.2
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	19.2
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	19.0
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	19.0
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	18.7
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	17.5
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	17.3
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	16.2
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	15.9
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	15.6
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	15.5
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	15.5
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	15.3
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	15.0
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	14.8
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	14.8
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	14.8
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	14.7
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	14.6
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	13.8
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	13.8
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	13.6
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	13.3
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	12.9
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	12.8
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	12.8
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	12.5
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	12.3
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	12.2
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	12.0
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	11.8
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	11.7
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	11.3
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	11.3
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	11.2
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	10.9
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	10.8
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	10.8
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	10.7
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	10.7
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	10.6
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	10.3
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	10.2
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	10.1
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	9.7
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	9.7
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	9.6
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	9.4
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	9.3
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	9.2
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	9.1
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	9.0
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	8.9
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	8.9
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	8.9
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	8.3
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	8.1
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	8.1
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	7.2
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	7.0
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	6.8
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	6.7
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	6.6
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	6.5
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	6.4
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	6.3
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	6.1
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	6.1
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	5.9
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	5.8
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	5.2
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	5.0
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	4.8
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	4.1
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	4.0
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	3.9
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	3.4
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	3.1
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	2.0
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	1.9
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	1.9
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	1.9
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	0.9
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

TGFB2 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 13.37

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

32.2

Number of samples

Samples

Sample	Description	TPM
AK103	N, NA, stage:NA, alive, 1320 days	120.1
AK003	N, NA, stage:NA, dead, 600 days	103.4
AK006	N, NA, stage:NA, dead, 360 days	96.0
AK005	N, NA, stage:NA, dead, 240 days	79.8
AK085	N, NA, stage:NA, alive, 660 days	68.9
AK053	N, NA, stage:NA, dead, 300 days	60.2
AK139	N, NA, stage:NA, dead, 270 days	60.1
AK236	N, NA, stage:NA, dead, 360 days	56.7
AK216	N, NA, stage:NA, dead, 360 days	55.2
AK089	N, NA, stage:NA, dead, 330 days	48.5
AK099	N, NA, stage:NA, dead, 420 days	47.5
AK227	N, NA, stage:NA, alive, 300 days	47.3
AK091	N, NA, stage:NA, dead, 210 days	42.2
AK199	N, NA, stage:NA, alive, 1860 days	42.1
AK081	N, NA, stage:NA, dead, 180 days	41.7
AK074	N, NA, stage:NA, alive, 300 days	40.4
AK133	N, NA, stage:NA, dead, 360 days	39.9
AK183	N, NA, stage:NA, alive, 360 days	38.3
AK035	N, NA, stage:NA, dead, 210 days	36.8
AK158	N, NA, stage:NA, dead, 360 days	36.5
AK231	N, NA, stage:NA, dead, 240 days	35.7
AK117	N, NA, stage:NA, dead, 210 days	35.2
AK123	N, NA, stage:NA, dead, 180 days	33.7
AK167	N, NA, stage:NA, dead, 180 days	33.4
AK041	N, NA, stage:NA, alive, 810 days	32.9
AK071	N, NA, stage:NA, dead, 540 days	32.3
AK188	N, NA, stage:NA, alive, 420 days	29.1
AK153	N, NA, stage:NA, dead, 240 days	28.1
AK142	N, NA, stage:NA, alive, 90 days	27.1
AK068	N, NA, stage:NA, alive, 360 days	26.2
AK049	N, NA, stage:NA, dead, 180 days	21.5
AK173	N, NA, stage:NA, dead, 180 days	21.4
AK055	N, NA, stage:NA, dead, 240 days	21.3
AK098	N, NA, stage:NA, dead, 660 days	20.6
AK088	N, NA, stage:NA, dead, 360 days	20.4
AK100	N, NA, stage:NA, alive, 960 days	19.5
AK178	N, NA, stage:NA, dead, 240 days	19.4
AK226	N, NA, stage:NA, dead, 360 days	19.1
AK051	N, NA, stage:NA, dead, 360 days	17.9
AK156	N, NA, stage:NA, dead, 330 days	17.7
AK076	N, NA, stage:NA, alive, 660 days	16.1
AK195	N, NA, stage:NA, dead, 390 days	15.1
AK079	N, NA, stage:NA, dead, 210 days	15.1
AK030	N, NA, stage:NA, dead, 120 days	15.0
AK072	N, NA, stage:NA, dead, 150 days	13.8
AK102	N, NA, stage:NA, alive, 1740 days	13.0
AK213	N, NA, stage:NA, alive, 2010 days	12.9
AK043	N, NA, stage:NA, alive, 660 days	12.5
AK165	N, NA, stage:NA, alive, 360 days	12.1
AK149	N, NA, stage:NA, dead, 420 days	11.8
AK015	N, NA, stage:NA, alive, 720 days	11.2
AK134	N, NA, stage:NA, dead, 360 days	10.8
AK218	N, NA, stage:NA, dead, 180 days	10.2
AK124	N, NA, stage:NA, alive, 1920 days	9.0
AK066	N, NA, stage:NA, alive, 960 days	7.9
AK205	N, NA, stage:NA, dead, 120 days	4.4
AK185	N, NA, stage:NA, alive, 330 days	4.4
AK002	N, NA, stage:NA, dead, 570 days	3.0
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0190360004	Tumor	2.0
CPT0218690004	Tumor	1.7
CPT0199770003	Tumor	1.6
CPT0093510003	Tumor	1.5
CPT0225730003	Tumor	1.4
CPT0205570003	Tumor	1.2
CPT0189750004	Tumor	1.2
CPT0206670004	Tumor	1.2
CPT0189570004	Tumor	1.0
CPT0224540004	Tumor	1.0
CPT0127480003	Tumor	0.9
CPT0168830003	Tumor	0.9
CPT0161730003	Tumor	0.8
CPT0167530003	Tumor	0.8
CPT0189850004	Tumor	0.8
CPT0217000004	Tumor	0.7
CPT0167640003	Tumor	0.6
CPT0225760003	Tumor	0.6
CPT0087570003	Tumor	0.5
CPT0064650003	Tumor	0.5
CPT0092440003	Tumor	0.5
CPT0182500003	Tumor	0.5
CPT0168590003	Tumor	0.5
CPT0218330004	Tumor	0.5
CPT0218830004	Tumor	0.4
CPT0217430008	Tumor	0.4
CPT0093360003	Tumor	0.4
CPT0218890004	Tumor	0.4
CPT0206000004	Tumor	0.4
CPT0168080003	Tumor	0.4
CPT0206880003	Tumor	0.3
CPT0217060003	Tumor	0.3
CPT0205450004	Tumor	0.3
CPT0087950003	Tumor	0.2
CPT0123530003	Tumor	0.2
CPT0127420003	Tumor	0.2
CPT0217100003	Tumor	0.2
CPT0224330003	Tumor	0.2
CPT0002410011	Tumor	0.2
CPT0189460003	Tumor	0.2
CPT0171580008	Tumor	0.2
CPT0224390004	Tumor	0.1
CPT0201710003	Tumor	0.1
CPT0093450003	Tumor	0.0
CPT0093590003	Tumor	0.0
CPT0093550003	Tumor	0.0
CPT0167970003	Tumor	0.0
CPT0189250003	Tumor	0.0
CPT0205780003	Tumor	0.0
CPT0186100003	Tumor	0.0
CPT0125510003	Tumor	-0.1
CPT0168480003	Tumor	-0.1
CPT0167750004	Tumor	-0.1
CPT0206560003	Tumor	-0.1
CPT0125570003	Tumor	-0.1
CPT0206450003	Tumor	-0.1
CPT0206780003	Tumor	-0.2
CPT0162100003	Tumor	-0.2
CPT0168270003	Tumor	-0.2
CPT0206110003	Tumor	-0.2
CPT0182550003	Tumor	-0.2
CPT0224600003	Tumor	-0.2
CPT0087730003	Tumor	-0.2
CPT0168380003	Tumor	-0.3
CPT0125220003	Tumor	-0.3
CPT0221180003	Tumor	-0.3
CPT0206230003	Tumor	-0.3
CPT0071100003	Tumor	-0.4
CPT0209440003	Tumor	-0.4
CPT0189650004	Tumor	-0.4
CPT0217190003	Tumor	-0.4
CPT0218960004	Tumor	-0.4
CPT0219080004	Tumor	-0.4
CPT0064890003	Tumor	-0.4
CPT0205670004	Tumor	-0.4
CPT0228220003	Tumor	-0.4
CPT0162020003	Tumor	-0.5
CPT0206330003	Tumor	-0.6
CPT0207030003	Tumor	-0.6
CPT0079790003	Tumor	-0.6
CPT0078580003	Tumor	-0.6
CPT0162140003	Tumor	-0.6
CPT0216920008	Tumor	-0.6
CPT0168720003	Tumor	-0.6
CPT0087680003	Tumor	-0.7
CPT0182580003	Tumor	-0.7
CPT0175060003	Tumor	-0.7
CPT0204420003	Normal	-0.8
CPT0196850003	Tumor	-0.9
CPT0104220003	Tumor	-0.9
CPT0218670003	Tumor	-0.9
CPT0104330003	Tumor	-0.9
CPT0204390003	Normal	-0.9
CPT0205890003	Tumor	-0.9
CPT0204370003	Normal	-0.9
CPT0204350003	Normal	-1.0
CPT0208980003	Tumor	-1.0
CPT0167860004	Tumor	-1.0
CPT0089150003	Tumor	-1.0
CPT0217880003	Tumor	-1.1
CPT0204410003	Normal	-1.2
CPT0218770003	Tumor	-1.2
CPT0204360003	Normal	-1.2
CPT0204380003	Normal	-1.4
CPT0204340003	Normal	-1.4
CPT0204400003	Normal	-1.4
CPT0204330003	Normal	-1.5
CPT0217710008	Tumor	-1.6
CPT0190240004	Tumor	-1.6
CPT0207090003	Tumor	-1.8
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis